← Back to Search

Behavioural Intervention

Supportive Care (MUSE S headband, meditation) for Breast Cancer

Q: What is the current capacity for patient enrollment in this clinical trial?

Affirmative. The details on clinicaltrials.gov indicate that this investigation is actively seeking participants. This trial was first listed on January 8th, 2024, and the most recent update occurred on February 22nd, 2024. In total, they aim to recruit 40 patients from a single site.

Q: Are there any vacancies available for patients to participate in this trial?

Indeed, details available on clinicaltrials.gov affirm the ongoing recruitment status of this investigation. The trial was initially published on January 8th, 2024 and recently revised on February 22nd, 2024. Specifically, the study aims to enroll a total of 40 participants from one designated site.

Q: Are individuals older than 18 years of age eligible to participate in this medical trial?

Eligible candidates for this research are individuals between 18 and 80 years old. It is noteworthy that there are a total of 61 trials catering to those under 18 and 2281 studies targeting participants over the age of 65.

Phase < 1

Recruiting

Led By Stacy D. D'Andre, M.D.

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 18-80

Breast cancer first diagnosed with stage 1-4 breast cancer in the past 10 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks

Awards & highlights

Study Summary

This trial is testing a meditation headband system called MUSE-S to see if it can help breast cancer survivors with anxiety and insomnia. These issues are common among breast cancer survivors and can affect their well

Who is the study for?

This trial is for breast cancer survivors who are experiencing anxiety and insomnia. Participants should be interested in trying a meditation headband system called MUSE-S to help manage their stress.Check my eligibility

What is being tested?

The study is testing the MUSE-S Headband System, which guides users through meditation using EEG technology. It aims to see if this device can improve well-being by reducing anxiety and insomnia among breast cancer survivors.See study design

What are the potential side effects?

Since the intervention involves non-invasive meditation therapy with a headband, there are minimal expected side effects. However, discomfort or skin irritation from wearing the device may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 80 years old.

Select...

My breast cancer was first diagnosed within the last 10 years.

Select...

I am experiencing anxiety and insomnia, both worse than 3 out of 10.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility of a wearable electroencephalographic (EEG) headband (Muse™ S Headband)

Frequency of use of meditation

Impact of interactive meditation and sleep support through the Muse-S™ system

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive Care (MUSE S headband, meditation)Experimental Treatment4 Interventions

Patients wear the MUSE S headband to bed every night for 8 weeks and meditate using the MUSE phone app during day hours for at least 5 minutes over 8 weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Meditation Therapy

2018

N/A

~50

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,216 Previous Clinical Trials

3,767,448 Total Patients Enrolled

83 Trials studying Breast Cancer

13,810 Patients Enrolled for Breast Cancer

Stacy D. D'Andre, M.D.Principal InvestigatorMayo Clinic in Rochester

1 Previous Clinical Trials

30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current capacity for patient enrollment in this clinical trial?

"Affirmative. The details on clinicaltrials.gov indicate that this investigation is actively seeking participants. This trial was first listed on January 8th, 2024, and the most recent update occurred on February 22nd, 2024. In total, they aim to recruit 40 patients from a single site."

Answered by AI

Are there any vacancies available for patients to participate in this trial?

"Indeed, details available on clinicaltrials.gov affirm the ongoing recruitment status of this investigation. The trial was initially published on January 8th, 2024 and recently revised on February 22nd, 2024. Specifically, the study aims to enroll a total of 40 participants from one designated site."

Answered by AI

Are individuals older than 18 years of age eligible to participate in this medical trial?

"Eligible candidates for this research are individuals between 18 and 80 years old. It is noteworthy that there are a total of 61 trials catering to those under 18 and 2281 studies targeting participants over the age of 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors

2024. "MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06274034.

All > Paid Studies Minneapolis